BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 20484028)

  • 1. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.
    Poschke I; Mougiakakos D; Hansson J; Masucci GV; Kiessling R
    Cancer Res; 2010 Jun; 70(11):4335-45. PubMed ID: 20484028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck.
    Chikamatsu K; Sakakura K; Toyoda M; Takahashi K; Yamamoto T; Masuyama K
    Cancer Sci; 2012 Jun; 103(6):976-83. PubMed ID: 22360618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines.
    Poschke I; Mao Y; Adamson L; Salazar-Onfray F; Masucci G; Kiessling R
    Cancer Immunol Immunother; 2012 Jun; 61(6):827-38. PubMed ID: 22080405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
    Hoechst B; Ormandy LA; Ballmaier M; Lehner F; Krüger C; Manns MP; Greten TF; Korangy F
    Gastroenterology; 2008 Jul; 135(1):234-43. PubMed ID: 18485901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms.
    Mao Y; Poschke I; Wennerberg E; Pico de Coaña Y; Egyhazi Brage S; Schultz I; Hansson J; Masucci G; Lundqvist A; Kiessling R
    Cancer Res; 2013 Jul; 73(13):3877-87. PubMed ID: 23633486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells.
    Giordano D; Magaletti DM; Clark EA; Beavo JA
    J Immunol; 2003 Dec; 171(12):6421-30. PubMed ID: 14662841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
    Höchst B; Schildberg FA; Sauerborn P; Gäbel YA; Gevensleben H; Goltz D; Heukamp LC; Türler A; Ballmaier M; Gieseke F; Müller I; Kalff J; Kurts C; Knolle PA; Diehl L
    J Hepatol; 2013 Sep; 59(3):528-35. PubMed ID: 23665041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.
    Rudolph BM; Loquai C; Gerwe A; Bacher N; Steinbrink K; Grabbe S; Tuettenberg A
    Exp Dermatol; 2014 Mar; 23(3):202-4. PubMed ID: 24495013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.
    Huang A; Zhang B; Wang B; Zhang F; Fan KX; Guo YJ
    Cancer Immunol Immunother; 2013 Sep; 62(9):1439-51. PubMed ID: 23760662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A9 a new marker for monocytic human myeloid-derived suppressor cells.
    Zhao F; Hoechst B; Duffy A; Gamrekelashvili J; Fioravanti S; Manns MP; Greten TF; Korangy F
    Immunology; 2012 Jun; 136(2):176-83. PubMed ID: 22304731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired dendritic cell differentiation and maturation in the absence of C3.
    Reis ES; Barbuto JA; Köhl J; Isaac L
    Mol Immunol; 2008 Apr; 45(7):1952-62. PubMed ID: 18061265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
    Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
    Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
    Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
    Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and prognostic significance of CD14 (+) HLA-DR (-/low) myeloid-derived suppressor cells in patients with hepatocellular carcinoma received transarterial radioembolization with Yttrium-90.
    Boral B; Ballı HT; Sözütok S; Pehlivan UA; Aikimbaev K
    Scand J Immunol; 2022 Mar; 95(3):e13132. PubMed ID: 34936119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.
    Jitschin R; Braun M; Büttner M; Dettmer-Wilde K; Bricks J; Berger J; Eckart MJ; Krause SW; Oefner PJ; Le Blanc K; Mackensen A; Mougiakakos D
    Blood; 2014 Jul; 124(5):750-60. PubMed ID: 24850760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
    Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
    Front Immunol; 2020; 11():613215. PubMed ID: 33679700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-induced CD14+HLA-DR (-/low) myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients.
    Wang Z; Zhang L; Wang H; Xiong S; Li Y; Tao Q; Xiao W; Qin H; Wang Y; Zhai Z
    Cancer Immunol Immunother; 2015 Mar; 64(3):389-99. PubMed ID: 25548095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection.
    Loré K; Sönnerborg A; Broström C; Goh LE; Perrin L; McDade H; Stellbrink HJ; Gazzard B; Weber R; Napolitano LA; van Kooyk Y; Andersson J
    AIDS; 2002 Mar; 16(5):683-92. PubMed ID: 11964524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.